Antibiotic use in children hospitalised with pneumonia in Central Vietnam
- 20 February 2020
- journal article
- research article
- Published by BMJ in Archives of Disease in Childhood
- Vol. 105 (8), 713-719
- https://doi.org/10.1136/archdischild-2019-317733
Abstract
Background and objectives Excessive use of antibiotics has been noted in children with respiratory tract infections in Vietnam, but antibiotic use in hospitalised children is poorly documented. Antibiotic use and direct healthcare costs in children hospitalised with pneumonia in central Vietnam were assessed. Methods A prospective descriptive study of children under 5 years old admitted with a primary admission diagnosis of ‘pneumonia’ to the Da Nang Hospital for Women and Children over 1 year. Results Of 2911 children hospitalised with pneumonia, 2735 (94.0%) were classified as ‘non-severe’ pneumonia by the admitting physician. In total, 2853 (98.0%) children received antibiotics. Intravenous antibiotics were given to 336 (12.3%) children with ‘non-severe’ and 157/176 (89.2%) children with ‘severe’ pneumonia; those with ‘non-severe’ pneumonia accounted for 68.2% (336/493) of intravenous antibiotics given. Only 19.3% (95/493) of children on intravenous antibiotics were stepped down to an oral antibiotic. Cefuroxime was the preferred oral agent, and ceftriaxone was the preferred injectable agent. Hospital admission for oral antibiotics in ‘non-severe’ pneumonia was a major cost driver, with an average direct cost of US$78.9 per patient, accounting for 54.0% of the total hospitalisation cost in the study cohort. In addition, 336 (12.3%) children with non-severe pneumonia received intravenous antibiotics without indication, accounting for a further 23.2% of hospitalisation costs. Conclusion Limiting unnecessary hospitalisation and considering early intravenous to oral step down antibiotic will reduce direct health system costs and morbidity in children with respiratory tract infections in Vietnam.Keywords
This publication has 29 references indexed in Scilit:
- Clinical management of community-acquired pneumonia in young childrenExpert Opinion on Pharmacotherapy, 2018
- The drug use to treat community-acquired pneumonia in childrenMedicine, 2018
- Estimates of the global, regional, and national morbidity, mortality, and aetiologies of lower respiratory infections in 195 countries, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016The Lancet Infectious Diseases, 2018
- Encouraging rational antibiotic use in childhood pneumonia: a focus on Vietnam and the Western Pacific RegionPneumonia, 2017
- Cost of management of severe pneumonia in young children: systematic analysisJournal of Global Health, 2016
- Childhood pneumonia in developing countriesThe Lancet Respiratory Medicine, 2013
- Global burden of childhood pneumonia and diarrhoeaThe Lancet, 2013
- Challenges to improving case management of childhood pneumonia at health facilities in resource-limited settingsBulletin of the World Health Organization, 2008
- Oral amoxicillin versus injectable penicillin for severe pneumonia in children aged 3 to 59 months: a randomised multicentre equivalency studyThe Lancet, 2004
- Etiology of severe pneumonia in children in developing countriesThe Pediatric Infectious Disease Journal, 1986